FDA.reportPublic FDA data

Mydayis 37.5 MG 24HR Extended Release Oral Capsule

RxCUI
1927639
RxNorm name
Mydayis 37.5 MG 24HR Extended Release Oral Capsule
Display name
Mydayis 37.5 MG 24HR Extended Release Oral Capsule
Full name
Mydayis 37.5 MG 24HR Extended Release Oral Capsule
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:38:48

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
MYDAYISDEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, AND AMPHETAMINE SULFATETakeda Pharmaceuticals America, Inc.141a7970-3f06-44ea-9ab7-aeece2c085fc2026-04-30Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 1927639

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
141a7970-3f06-44ea-9ab7-aeece2c085fcMydayis 37.5 MG 24HR Extended Release Oral Capsule [PSN] · 3-Bead 24 HR amphetamine aspartate 9.375 MG / amphetamine sulfate 9.375 MG / dextroamphetamine saccharate 9.375 MG / dextroamphetamine sulfate 9.375 MG Extended Release Oral Capsule [Mydayis] [SBD] · Mydayis 37.5 MG 24HR Extended Release Oral Capsule [SY]313These highlights do not include all the information needed to use MYDAYIS safely and effectively. See full prescribing information for MYDAYIS. MYDAYIS ® (mixed salts of a single-entity amphetamine product) extended-release capsules, for oral use, CII Initial U.S. Approval: 200120260430